What question did this study set out to answer?

To evaluate the long-term effects of ketamine treatment on patients with treatment-resistant depression.

April 10, 2026

Ketamine shows long‐term benefit in patients with treatment‐resistant depression

Puntos clave

To evaluate the long-term effects of ketamine treatment on patients with treatment-resistant depression.
Administered ketamine or esketamine treatments to patients
Monitored emergency department visits related to suicidality
Assessed response rates of depression symptoms over 6 months
60% reduction in emergency department visits related to suicidality
56.7% response rate of depression symptoms after treatment

Resumen

Patients with treatment‐resistant depression who received a series of treatments with ketamine or esketamine showed a substantial reduction in emergency department visits related to suicidality over a 6‐month period, a study has found. Study participants had a 56.7% response rate of depression symptoms following the acute phase of treatment.

Me gusta

Guardar

Cite This Study

A Wed, study studied this question.

synapsesocial.com/papers/69d895be6c1944d70ce06e42 https://doi.org/https://doi.org/10.1002/pu.31440